During the quarter to be reported, ResMed launched the AirCurve 10 series platform in the U.S. to provide personalized treatment to patients suffering from sleep apnea. The company also launched the world's first non-contact personal sleep monitoring device - S+. We believe such innovations will expand the company's shares in the core sleep apnea market and will consequently boost its sales in the quarters going forward.